机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Zingman, LV
Hodgson, DM
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Hodgson, DM
Bast, PH
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Bast, PH
Kane, GC
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Kane, GC
Perez-Terzic, C
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Perez-Terzic, C
Gumina, RJ
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Gumina, RJ
Pucar, D
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Pucar, D
Bienengraeber, M
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Bienengraeber, M
Dzeja, PP
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Dzeja, PP
Miki, T
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Miki, T
Seino, S
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Seino, S
Alekseev, AE
论文数: 0引用数: 0
h-index: 0
机构:Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Alekseev, AE
Terzic, A
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USAMayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
Terzic, A
[1
]
机构:
[1] Mayo Clin, Div Cardiovasc Dis, Dept Med & Mol Pharmacol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Cardiovasc Dis, Dept Expt Therapeut, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA
[4] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, Chiba 2608670, Japan
Reaction to stress requires feedback adaptation of cellular functions to secure a response without distress, but the molecular order of this process is only partially understood. Here, we report a previously unrecognized regulatory element in the general adaptation syndrome. Kir6.2, the ion-conducting subunit of the metabolically responsive ATP-sensitive potassium (K(ATP)) channel, was mandatory for optimal adaptation capacity under stress. Genetic deletion of Kir6.2 disrupted K(ATP) channel-dependent adjustment of membrane excitability and calcium handling, compromising the enhancement of cardiac performance driven by sympathetic stimulation, a key mediator of the adaptation response. In the absence of Kir6.2, vigorous sympathetic challenge caused arrhythmia and sudden death, preventable by calcium-channel blockade. Thus, this vital function identifies a physiological role for K(ATP) channels in the heart.